Recognized standard
F2602-18
FDA recognition 15-62 · ASTM · Tissue Engineering
Key facts
| Recognition number | 15-62 |
|---|---|
| Designation | F2602-18 |
| Title | Standard Test Method for Determining the Molar Mass of Chitosan and Chitosan Salts by Size Exclusion Chromatography with Multi-angle Light Scattering Detection (SEC-MALS) |
| Standards developer | ASTM International |
| Specialty area | Tissue Engineering |
| Date of entry | Jul 6, 2020 |
| Scope (excerpt) | 1.1 This test method covers the determination of the molar mass of chitosan and chitosan salts intended for use in biomedical and pharmaceutical applications as well as in tissue engineered medical products (TEMPs) by exclusion chromatography with multi-angle laser light scattering detection… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: